期刊文献+

冠心病患者同型半胱氨酸水平变化与血管内皮功能的关系 被引量:13

Alteration of blood homocysteine in patients with coronary heart disease and its correlation with the vascular endothelial function
下载PDF
导出
摘要 目的:探讨血浆同型半胱氨酸水平变化对冠心病患病的意义以及与内皮素、一氧化氮的相关性。方法:分别测定115例冠心病患者和52例正常对照组血浆同型半胱氨酸及血脂各参数、内皮素、一氧化氮水平,并进行比较。结果:冠心病组的同型半胱氨酸、内皮素水平均明显高于对照组(P<0.01),而一氧化氮低于对照组(P<0.01)。结论:半胱氨酸与冠心病具有密切联系,高同型半胱氨酸是同型半胱氨酸患者的一个新的危险因素,检测血浆同型半胱氨酸对预防和诊治冠心病具有一定临床价值。 Objective To investigate the implication of hyperhomocysteinemia in coronary heart disease and the correlation between homocysteine and the vascular endothelial function. Methods The fasting plasma total homocysteine, serum triglyceride, total cholesterol, high density lipoproteincholesterol, low density lipoprotein-cholesterol, nitrogen monoxide and endothelin of 115 case of affirmed coronary heart disease and 52 age and gender matched controls were determined respectively. Statistical analysis was done to all measured parameters. Results The homocysteine and ET levels were significantly higher in coronary heart disease group than those in control group. The nitrogen monoxide levels were significantly lower in coronary heart disease group than those in control group. Conclusion Plasma homocysteine level is closely related with coronary heart disease and hyperhomocysteinemia is a risk factor for coronary heart disease.
出处 《实用诊断与治疗杂志》 2005年第5期327-328,共2页 Journal of Practical Diagnosis and Therapy
关键词 冠心病 同型半胱氮酸 内皮素 一氧化氮 Coronary heart disease homocysteine endothelin nitrogen monoxide
  • 相关文献

参考文献8

二级参考文献19

  • 1李昌棣,叶怀莲,闵姜勇,邓新,毛亚平.高胱氨酸血症与冠心病关系的临床观察及动物实验[J].中华老年医学杂志,1994,13(1):49-50. 被引量:20
  • 2Swanson DR, Barclay BL, Wong PSL, et al. Nifedipine gastronintestina therapeutic system. Am J Med, 1987,83(Suppl 6B):3.
  • 3Chung M, Reitberg DP,Gaffney M,et al. Clinical pharmacokintics of nifedipine gastronintestinal therapeutic system:a controlled-release fornulation of nifedipine. Am J Med, 1987,83(Suppl 6 B) : 10.
  • 4Berelowitz M,Fischette C,Cefalu W,et al. Comparative efficacy of a oncedaily controlled-release formulation of glipizide and immediate- releaseglipizide in patients with NIDDM. Diabetes Care, 1994,17:1460.
  • 5Berelowitz M. Contrasting influences of glipizide GITS and glibenlamide on fasting and post sustacal glycemia,glucose production,and 24h glucose/insulin profiles in NIDDM. Diabetes, 1996,45 (Suppl2) :285A.
  • 6Cefalu WT,BelI-Farrow AD, Wang ZQ, et al. Insulin sensitivity in vivo is improved after glipizide GITS treament. Diabetes, 1995,44(Suppl 2) : 107A.
  • 7Koenig W, Sund M, Fohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men:results from the MONICA Augsburg cohort study 1984-1992[J]. Circulation, 1999, 99(2):237
  • 8Abdelmouttaleb I, Danchin N, Ilaedo C, et al. C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes[J]. Am Heart J,1999,137(2) :346
  • 9Geza S B, Sharon P, Yvonne L, et al. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction[J]. Clin Chem,1992,38(11):2203
  • 10Orlic D, Kajstura J, Chimenti S, et al. Bone marrow stem cells regenerate infracted myocardium[J]. Pediatr Transplant,2003,7(3 Suppl) :86

共引文献15

同被引文献97

引证文献13

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部